PepLabo Download

Foundayo™ and body aches

Aching joints, a sore back or muscles that feel heavy are common complaints for anyone changing their eating and activity, with or without medicine. For Foundayo™ there is a useful check: the two big weight trials published how often joint and back pain were reported on orforglipron and on placebo. This page goes through those numbers, the label’s one entry about unusual skin sensations, a drug interaction relevant to muscle pain, and the warning signs that need care quickly.

Published · Updated · Foundayo™: side effects by symptom · Written by the PepLabo editorial team

Muscles and joints in the product information

Foundayo™ is a once-daily tablet of orforglipron, a GLP-1 receptor agonist that the published trials call a small-molecule, non-peptide drug [7]. Its label lists no muscle, joint or back pain among side effects [1]. The nearest entry is dysesthesia, a term for abnormal sensations, which the label reports separately with its own rates [1]. The Medication Guide does not mention aches [2].

Aches and sensations in Foundayo™ product information, checked 20 October 2026
SourceEntryComparison
US Prescribing Information, Table 1 [1]No joint, muscle or back pain rowTable lists reactions in at least 5% and above placebo
US Prescribing Information, section 6.1 [1]Dysesthesia: 5.5 mg 0%, 9 mg 0.3%, 17.2 mg 1%Placebo 0.1%
US Prescribing Information, section 7.2 [1]Simvastatin: do not exceed 20 mg a day with Foundayo™Active simvastatin acid exposure doubled
European Medicines Agency [3]CHMP positive opinion of 15 October 2026; product information pendingNo section 4.8 data
Health Canada [4]No entry in the Drug Product DatabaseNo monograph

Joint and back pain in the weight trials

The registry results of ATTAIN-1 and ATTAIN-2, the trials behind the label, list every event that affected at least 5% of any group, and joint and back pain cleared that bar [5][6]. The label converts the trial doses of 6, 12 and 36 mg to Foundayo™ strengths of 5.5, 9 and 17.2 mg [1].

Share of people reporting joint or back pain over 72 weeks
Event and trial [source]Placebo5.5 mg / 9 mg / 17.2 mg
Joint pain, ATTAIN-1, no diabetes [5]6.3%4.7% / 5.1% / 4.8%
Back pain, ATTAIN-1 [5]5.7%4.6% / 5.2% / 6.2%
Joint pain, ATTAIN-2, type 2 diabetes [6]5.1%5.2% / 4.2% / 4.7%
Back pain, ATTAIN-2 [6]4.3%5.5% / 3.9% / 6.5%

Reading the musculoskeletal numbers

  • Joint pain was, if anything, slightly less common on orforglipron than on placebo in ATTAIN-1, and about equal in ATTAIN-2 [5][6]. These are raw shares, not tested comparisons, so “no clear difference” is the fair summary.
  • Back pain was a little higher on the top dose in both trials, but the middle dose was at or below placebo, which argues against a simple dose effect [5][6].
  • In smaller diabetes trials that list every event, muscle pain (myalgia) appeared in one person or none per orforglipron group, and gout in two people on orforglipron in ACHIEVE-2, against none on dapagliflozin [8][9].
  • Some sensation terms, such as paraesthesia (tingling) and hyperaesthesia (heightened sensitivity), clustered on the 36 mg dose in ACHIEVE-2, with three people each out of 241 and none on dapagliflozin [9]. That matches the direction of the label’s dysesthesia figures but remains a small count.

Possible routes from the tablet to an ache

Label-supported: dehydration. Nausea, vomiting and diarrhoea are the commonest Foundayo™ reactions and can lead to fluid loss [1]; MedlinePlus lists muscle cramps among signs of mild to moderate dehydration [12].

Label-supported: the simvastatin interaction. In a drug-interaction study, orforglipron raised levels of simvastatin acid, the active form, two- to two-and-a-half-fold, and the label says a twofold rise at the highest simvastatin dose could be clinically meaningful [1]. It does not describe what that effect would be. MedlinePlus lists statins among medicines that can cause muscle pain [10]. The label’s limit applies to simvastatin only; it lists smaller rises for atorvastatin (about 1.5-fold) and rosuvastatin (about 1.7-fold) without a dose instruction [1].

Proposed but unmeasured: the dysesthesia rate rose with dose and was zero on 5.5 mg [1], but the label offers no explanation, and no study has examined its cause.

General: the trials paired the tablet with diet and activity counselling, with a target of at least 150 minutes of activity a week [1]. MedlinePlus says most muscle pain comes from overuse, tension or injury during exercise or physical work [10], so new activity is a likely cause of soreness in its own right.

Other common causes

MedlinePlus lists many reasons for aching muscles and joints [10][11]:

  • Overuse, strains, sprains and stress.
  • Viral infections such as flu.
  • Osteoarthritis, gout and pseudogout, bursitis and tendinitis.
  • Rheumatoid arthritis, lupus, polymyalgia rheumatica and fibromyalgia.
  • Low potassium or calcium.
  • Medicines including statins and ACE inhibitors for blood pressure.

What general sources suggest

For aches from overuse, MedlinePlus suggests resting the area, ice in the first days after an injury and heat afterwards, gentle stretching, massage, plenty of sleep and less stress [10]. It recommends warming up, cooling down, stretching and drinking fluids around exercise, and starting new workouts slowly [10].

MedlinePlus also mentions acetaminophen, or anti-inflammatories such as ibuprofen, for some aches [10][11]. Ask your pharmacist before adding any of these: Foundayo™ slows stomach emptying and the label notes this can change how other oral medicines are absorbed [1].

If you take a statin, keep its name and dose on your medicine list. The Medication Guide asks you to tell your provider about all prescription and over-the-counter medicines, because Foundayo™ may affect how some of them work [2].

Points specific to Foundayo™

The label reports that weight lost on Foundayo™ came more from fat than from lean mass [1]. It does not report muscle strength or pain, so this is reassurance about body composition, not about aches.

Dysesthesia appeared only on the 9 mg and 17.2 mg doses [1]. If a burning, prickling or unusually sensitive patch of skin appears after a dose step, noting the date and the dose gives your prescriber the context the label itself suggests matters.

Foundayo™ is a trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.

When to get help

SignWho to contactHow fastSource
Muscle weakness or being unable to move part of the body, trouble swallowing or shortness of breathEmergency servicesEmergencyMedlinePlus [10]
Muscle pain with urinating much less than usual, vomiting, a very stiff neck or high feverEmergency servicesEmergencyMedlinePlus [10]
Muscle pain that began after starting or changing a medicine such as a statinYour healthcare providerTodayMedlinePlus [10]
Nausea, vomiting or diarrhoea that does not go away, with cramps or little urineYour prescriber, right awayTodayFoundayo™ Medication Guide [2]
Severe, unexplained joint pain and swelling, especially with other unexplained symptomsYour healthcare providerTodayMedlinePlus [11]
Muscle pain lasting more than three days, or joint pain lasting more than several daysYour healthcare providerAt your next appointmentMedlinePlus [10][11]

Questions

Does Foundayo™ cause joint pain?

It is not listed in the label. In ATTAIN-1 joint pain was reported by 4.7% to 5.1% on orforglipron and 6.3% on placebo [1][5].

What is dysesthesia on the Foundayo™ label?

An abnormal and sometimes unpleasant sensation. The label reports it in 0.3% on 9 mg and 1% on 17.2 mg, against 0.1% on placebo and none on 5.5 mg [1].

I take simvastatin. Does that matter?

Yes. Orforglipron doubled the active form of simvastatin in a study, and the label says not to exceed 20 mg of simvastatin a day with Foundayo™; your prescriber will check your dose [1].

Are atorvastatin and rosuvastatin affected too?

Their levels rose less, by about 1.5-fold and 1.7-fold, and the label gives no dose limit for them [1]. Your prescriber can review any statin you take.

Could my new exercise routine be the reason?

Quite possibly. MedlinePlus says most muscle pain is linked to overuse or injury from exercise or physical work [10].

Is gout linked to Foundayo™?

The label does not mention gout. In the ACHIEVE-2 registry results, two people on orforglipron and none on dapagliflozin reported it [9].

Sources

Sources checked on

  1. FOUNDAYO™ (orforglipron) tablets Prescribing Information, Eli Lilly and Company Revised 07/2026. Sections 5.4, 6.1 (Table 1, Dysesthesia), 7.2 (Table 3), 7.3, 12.2, 12.3 (Table 5) and 14.
  2. FOUNDAYO™ (orforglipron) Medication Guide, Eli Lilly and Company Issued 07/2026.
  3. Foundayo: opinion and summary of positive opinion (EMA/CHMP/229918/2026), European Medicines Agency Opinion adopted 15/10/2026; no EMA product information available yet.
  4. Drug Product Database, Health Canada Searched for Foundayo and orforglipron on 20 October 2026: no entry.
  5. A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-1), results, ClinicalTrials.gov NCT05869903. Adverse events at 5% or more.
  6. A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes (ATTAIN-2), results, ClinicalTrials.gov NCT05872620. Adverse events at 5% or more.
  7. Wharton S et al. Orforglipron, an oral small-molecule GLP-1 receptor agonist for obesity treatment (ATTAIN-1). N Engl J Med 2025 Randomised controlled trial; abstract.
  8. A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (ACHIEVE-1), results, ClinicalTrials.gov NCT05971940. All adverse events listed.
  9. A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin (ACHIEVE-2), results, ClinicalTrials.gov NCT06192108. All adverse events listed.
  10. Muscle aches, MedlinePlus Medical Encyclopedia
  11. Joint pain, MedlinePlus Medical Encyclopedia
  12. Dehydration, MedlinePlus Medical Encyclopedia

Set up your lab tonight.

It takes a few minutes. Pep will be waiting.